Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 5liposomal doxorubicin 4Topotecan 3Doxorubicin 2Carboplatin 2Bevacizumab 2saracatinib 1pegfilgrastim 1olaparib 1cediranib 1atezolizumab 1Taxes 1Poly(ADP-ribose) Polymerase Inhibitors 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Ifosfamide 1Gemcitabine 1Disulfides 1Diathermy 1Chemotherapy, Adjuvant 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Fallopian Tube Neoplasms × Diathermy × Clear all
NCT00045461 2013-08-07

Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

National Cancer Institute (NCI)

Phase 2/3 Unknown
241 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡